Ophthalmology
Volume 115, Issue 2 , Pages 334-341, February 2008

Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration:

The Blue Mountains Eye Study

  • Jennifer S.L. Tan, MBBS, BE

      Affiliations

    • Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, University of Sydney, Sydney, Australia.
  • ,
  • Jie Jin Wang, MMed, PhD

      Affiliations

    • Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, University of Sydney, Sydney, Australia.
    • Human Nutrition Unit, Department of Molecular and Microbial Biosciences, University of Sydney, Sydney, Australia.
  • ,
  • Victoria Flood, MPH, PhD

      Affiliations

    • Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, University of Sydney, Sydney, Australia.
  • ,
  • Elena Rochtchina, MApplStat

      Affiliations

    • Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, University of Sydney, Sydney, Australia.
  • ,
  • Wayne Smith, PhD, FAFPHM

      Affiliations

    • Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, Australia.
  • ,
  • Paul Mitchell, MD, PhD

      Affiliations

    • Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, University of Sydney, Sydney, Australia.
    • Corresponding Author InformationCorrespondence to Paul Mitchell, MD, PhD, Eye Clinic, Westmead Hospital, Hawkesbury Road, Westmead, NSW, Australia, 2145.

Received 11 December 2006; received in revised form 22 March 2007; accepted 22 March 2007. published online 02 August 2007.

Available online: July 30, 2007.

Purpose

To assess the relationship between baseline dietary and supplement intakes of antioxidants and the long-term risk of incident age-related macular degeneration (AMD).

Design

Australian population–based cohort study.

Participants

Of 3654 baseline (1992–1994) participants initially 49 years of older, 2454 were reexamined after 5 years, 10 years, or both.

Methods

Stereoscopic retinal photographs were graded using the Wisconsin Grading System. Data on potential risk factors were collected. Energy-adjusted intakes of α-carotene; β-carotene; β-cryptoxanthin; lutein and zeaxanthin; lycopene; vitamins A, C, and E; and iron and zinc were the study factors. Discrete logistic models assessed AMD risk. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated after adjusting for age, gender, smoking, and other risk factors.

Main Outcome Measures

Incident early, late, and any AMD.

Results

For dietary lutein and zeaxanthin, participants in the top tertile of intake had a reduced risk of incident neovascular AMD (RR, 0.35; 95% CI, 0.13–0.92), and those with above median intakes had a reduced risk of indistinct soft or reticular drusen (RR, 0.66; 95% CI, 0.48–0.92). For total zinc intake the RR comparing the top decile intake with the remaining population was 0.56 (95% CI, 0.32–0.97) for any AMD and 0.54 (95% CI, 0.30–0.97) for early AMD. The highest compared with the lowest tertile of total β-carotene intake predicted incident neovascular AMD (RR, 2.68; 95% CI, 1.03–6.96; P = 0.029, for trend). Similarly, β-carotene intake from diet alone predicted neovascular AMD (RR comparing tertile 3 with tertile 1, 2.40; 95% CI, 0.98–5.91; P = 0.027, for trend). This association was evident in both ever and never smokers. Higher intakes of total vitamin E predicted late AMD (RR compared with the lowest tertile, 2.83; 95% CI, 1.28–6.23; and RR, 2.55; 95% CI, 1.14–5.70 for the middle and highest tertiles, respectively; P = 0.22, for trend).

Conclusions

In this population-based cohort study, higher dietary lutein and zeaxanthin intake reduced the risk of long-term incident AMD. This study confirmed the Age-Related Eye Disease Study finding of protective influences from zinc against AMD. Higher β-carotene intake was associated with an increased risk of AMD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Manuscript no. 2006-1418.

 Supported by the Australian National Health & Medical Research Council, Canberra, Australia (grant nos. 974159, 211069).

 The authors have no conflicts of interest to declare.

PII: S0161-6420(07)00474-5

doi:10.1016/j.ophtha.2007.03.083

Ophthalmology
Volume 115, Issue 2 , Pages 334-341, February 2008